Home / Data / Women's Health Trial Tracker Women's Health Trial Tracker Women's Health Trial Tracker organizes records from ClinicalTrials.gov API v2 into a static table for transparent comparison. It preserves official source links and dates, marks missing enrichment, and adds deterministic grouping, change, recency, trend, or significance fields only where the documented inputs support them, without recommendations or unsupported claims.
Records 5,000
Last changed 08/26/2026
Update schedule 55 1 * * * UTC
Coverage 05/26/2000–08/25/2026 Record Record Date Vuga Group Change Status Recency Days Public Significance Score The SONImage Study 10/14/2019 INTERVENTIONAL unchanged 2,508.85 0 Neoadjuvant Study of Pyrotinib in HER-2 Positive Breast Cancer 10/15/2019 INTERVENTIONAL unchanged 2,507.85 0 Effect of Addition of Steroids on Duration of Analgesia 10/15/2019 INTERVENTIONAL unchanged 2,507.85 0 In Vitro Fertilisation Versus Intracytoplasmic Sperm Injection in Patients Without Severe Male Factor Infertility 10/16/2019 INTERVENTIONAL unchanged 2,506.85 0 Intraperitoneal Infusion of Analgesic for Postoperative Pain Management 10/17/2019 INTERVENTIONAL unchanged 2,505.85 0 HPV DNA Vaccine Via Electroporation for HPV16 Positive Cervical Neoplasia 10/18/2019 INTERVENTIONAL unchanged 2,504.85 0 Xenografts Development From Surgical Tumor Samples of Patients With Triple Negative or Luminal B Breast Cancer 10/21/2019 INTERVENTIONAL unchanged 2,501.85 0 ExclUsive endocRine Therapy Or Radiation theraPy for Women Aged ≥70 Years Early Stage Breast Cancer 10/22/2019 INTERVENTIONAL unchanged 2,500.85 0 Effects of a Physical Exercise Intervention During Neoadjuvant Chemotherapy in Women With Breast Cancer 10/22/2019 INTERVENTIONAL unchanged 2,500.85 0 Albumin-bound Paclitaxel and Carboplatin Versus Epirubicin and Docetaxel for Triple-negative Breast Cancer 10/23/2019 INTERVENTIONAL unchanged 2,499.85 0 Treatment of Triple-negative Breast Cancer With Albumin-bound Paclitaxel as Neoadjuvant Therapy: a Prospective RCT 10/24/2019 INTERVENTIONAL unchanged 2,498.85 0 Nab-paclitaxel Plus Carboplatin Versus Nab-paclitaxel Plus Epirubicin in the Neoadjuvant Therapy for Breast Cancer 10/24/2019 INTERVENTIONAL unchanged 2,498.85 0 Autonomic Determinants of POTS - Pilot 2 10/28/2019 INTERVENTIONAL unchanged 2,494.85 0 LUMIERE on the FETUS 10/29/2019 OBSERVATIONAL unchanged 2,493.85 0 A Study to Evaluate the PK and PD of IM or SQ Injections of Levonorgestrel Butanoate (LB) for Female Contraception 10/29/2019 INTERVENTIONAL unchanged 2,493.85 0 A Vaccine (H2NVAC) Before Surgery for the Treatment of HER2-Expressing Ductal Carcinoma In Situ 10/30/2019 INTERVENTIONAL unchanged 2,492.85 0 Von Willebrand Factor in Pregnancy (VIP) Study 10/31/2019 OBSERVATIONAL unchanged 2,491.85 0 IVM With Low Cost Priming, Enhanced Oocyte Recovery, and Delayed Transfer 11/04/2019 INTERVENTIONAL unchanged 2,487.85 0 Conservative Endometrioma Surgery 11/05/2019 INTERVENTIONAL unchanged 2,486.85 0 Quality of Life, Unmet Needs and Satisfaction With Care After Vulvar Cancer 11/05/2019 OBSERVATIONAL unchanged 2,486.85 0 Exosome Cargo From Preeclampsia Patients 11/06/2019 OBSERVATIONAL unchanged 2,485.85 0 Optical Biopsy in Gynecological Surgery 11/06/2019 INTERVENTIONAL unchanged 2,485.85 0 Creation and Validation of a Questionnaire Evaluating Diastasis Recti 11/08/2019 OBSERVATIONAL unchanged 2,483.85 0 Endocrine Therapy With Abemaciclib or Chemotherapy as Initial Metastatic Treatment in ER+/HER2- Breast Cancer 11/08/2019 INTERVENTIONAL unchanged 2,483.85 0 Radical Local vs. Palliative Therapy for Breast Cancer Patientts With Ipsilateral Humerus or Sternum Oligometastasis 11/12/2019 INTERVENTIONAL unchanged 2,479.85 0 Nab-paclitaxel Plus Carboplatin Versus Nab-paclitaxel Plus Capecitabine in the Treatment of Advanced Triple-negative Breast Cancer 11/12/2019 INTERVENTIONAL unchanged 2,479.85 0 Treatment of Metastatic Vulvar Carcinoma With Carboplatin and Paclitaxel Chemotherapy 11/13/2019 INTERVENTIONAL unchanged 2,478.85 0 Trigger Timing in Ovarian Stimulations 11/14/2019 INTERVENTIONAL unchanged 2,477.85 0 Ovarian Hyperstimulation and Fibrin Clot Properties. 11/18/2019 INTERVENTIONAL unchanged 2,473.85 0 Ventricular Repolarization in Patients With Premature Ovarian Insufficiency (QTIOP) 11/18/2019 INTERVENTIONAL unchanged 2,473.85 0 Preimplantation Genetic Testing in Women of Advanced Maternal Age 11/19/2019 INTERVENTIONAL unchanged 2,472.85 0 Impact of COVID-19 Pandemic on Out-of-Pocket Costs, Lost Wages, and Unemployment in Patients With Breast Cancer Undergoing Breast Surgery 11/20/2019 OBSERVATIONAL unchanged 2,471.85 0 A Study of IMP4297 as Maintenance Treatment Following First-line Chemotherapy in Patients With Advanced Ovarian Cancer 11/20/2019 INTERVENTIONAL unchanged 2,471.85 0 Lifestyles and Breast Cancer 11/22/2019 INTERVENTIONAL unchanged 2,469.85 0 Self Reported Pain in Women While Undergoing Treatment for Non-metastatic Breast Cancer 11/22/2019 OBSERVATIONAL unchanged 2,469.85 0 Prospective Randomized Study of Accelerated Radiation Therapy (PRART) 11/22/2019 INTERVENTIONAL unchanged 2,469.85 0 CFI-400945 and Durvalumab in Patients With Advanced Triple Negative Breast Cancer 11/25/2019 INTERVENTIONAL unchanged 2,466.85 0 Treatment of Chronic Pelvic Pain Due to Endometriosis by Transcutaneous Auricular Vagus Nerve Stimulation 11/26/2019 INTERVENTIONAL unchanged 2,465.85 0 Vitamin D and Health Status of British African-Caribbean Women 11/27/2019 OBSERVATIONAL unchanged 2,464.85 0 Intraoperative Costs and Patient Perceptions in Sacrocolpopexy for Prolapse 11/27/2019 OBSERVATIONAL unchanged 2,464.85 0 Safety of Lower Scalp Cooling Temperature to Prevent Hair Loss From Chemotherapy in Breast Cancer Patients 11/27/2019 INTERVENTIONAL unchanged 2,464.85 0 Effects of Prior Induced Termination of Pregnancy on Complications and Pregnancy Outcomes. 12/03/2019 OBSERVATIONAL unchanged 2,458.85 0 Association of Body Fluid Distribution With Obstructive Sleep Apnea in Pregnant Women With Body Mass Index ≥ 40 kg/m2 12/05/2019 OBSERVATIONAL unchanged 2,456.85 0 Treatment of Locally Advanced VULvar CArcinoma in a Neoadjuvant Setting With Carboplatin and Paclitaxel Chemotherapy (VULCANize) 12/10/2019 INTERVENTIONAL unchanged 2,451.85 0 Study Comparing EC-T Verses PCb in the Adjuvant Chemotherapy of Non-triple Negative Breast Cancer 12/10/2019 INTERVENTIONAL unchanged 2,451.85 0 Pregnancy in Women With Rare Multisystemic Vascular Diseases: COGRare5 Study 12/11/2019 OBSERVATIONAL unchanged 2,450.85 0 Breastfeeding and Gut Health 12/11/2019 OBSERVATIONAL unchanged 2,450.85 0 Study of the Impact of DPD Activity on the Efficacy of Capecitabine 12/13/2019 INTERVENTIONAL unchanged 2,448.85 0 Immediate Postpartum Glucose Tolerance Testing 12/16/2019 OBSERVATIONAL unchanged 2,445.85 0 Prehabilitation Care for Women With Advanced Ovarian Cancer Receiving Neoadjuvant Chemotherapy 12/19/2019 INTERVENTIONAL unchanged 2,442.85 0
Source U.S. National Library of Medicine, ClinicalTrials.gov API v2 · official record · retrieved 08/26/2026 · upstream last modified 08/26/2026
Licence United States government work; public domain unless the source record says otherwise. Source: U.S. National Library of Medicine
Required notice Study records are informational and do not provide diagnosis, treatment advice, or an assessment of individual risk. What we add We compute Vuga Group, Change Status, Recency Days, Public Significance Score using the documented compute method. · methodology